STOCK TITAN

Colgate-Palmolive Company (CL) Financials

CL NYSE
Trailing 12 months to September 30, 2026
Revenue $21.3B +5.9% YoY
Net Income $2.1B -29.3% YoY
EPS (Diluted) $2.56 -28.3% YoY
Free Cash Flow $3.8B +10.0% YoY
Market Cap $77.0B as of Nov 19, 2026
Price / Sales 3.6x on $21.3B revenue, trailing 12 months to September 30, 2026
Price / Earnings 37.5x on $2.1B net income, trailing 12 months to September 30, 2026
Price / Book 267x on $288.0M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CL SEC filings page.

Colgate-Palmolive Company (CL) reported $21.3B in revenue over the twelve months to Sep 30, 2026, up 5.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CL FY2025

Colgate’s revenue barely grew in FY2025, while operating profit weakened and cash generation held up against an almost-empty equity base.

The unusual cash–profit split is that operating income fell 22.5% while free cash flow rose 2.5%: cash conversion strengthened even as reported profitability weakened. That gap indicates non-cash items or working-capital movements cushioned cash generation, so the earnings decline did not translate proportionally into funds produced.

Revenue increased only 1.4% while operating margin fell 5.0 percentage points, indicating that FY2025’s weakness arose mainly below gross profit rather than from a sharp demand contraction. Gross margin slipped just 0.4 percentage points as selling, general and administrative expense rose 2.3%, pointing to heavier overhead pressure.

Equity shrank to $54M while liabilities reached 97.8% of assets, leaving a capital structure where a very small equity base magnifies reported returns. A 0.8x current ratio alongside 127.2x debt-to-equity points to tight short-term coverage and little loss-absorbing equity.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 61 / 100
Financial Health Score 61/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Colgate-Palmolive Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
83

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Colgate-Palmolive Company scores 83/100 on it among other operating companies.

Growth
39

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Colgate-Palmolive Company scores 39/100 on it among other operating companies.

Leverage
53

Colgate-Palmolive Company's net debt of $5.6B, being $6.9B of long-term debt less $1.3B of cash, came to 1.42 times its EBITDA in fiscal year 2025. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Colgate-Palmolive Company scores 53/100 among other operating companies measured the same way.

Liquidity
13

Colgate-Palmolive Company held $0.83 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 0.83. Liquidity ranks operating companies on that ratio, and Colgate-Palmolive Company scores 13/100 among other operating companies.

Cash Flow
82

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Colgate-Palmolive Company scores 82/100 on it among other operating companies.

Returns
94

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Colgate-Palmolive Company scores 94/100 on it among other operating companies.

Altman Z-Score Safe
7.01

Colgate-Palmolive Company scores 7.01, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $77.0B against total liabilities of $16.0B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Colgate-Palmolive Company passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.97x

For every $1 of reported earnings, Colgate-Palmolive Company generates $1.97 in operating cash flow ($4.2B OCF vs $2.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
12.38x

Colgate-Palmolive Company earns $12.38 in operating income for every $1 of interest expense ($3.3B vs $267.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$5.4B
YoY+4.6%
QoQ+0.1%
5Y CAGR+4.0%
10Y CAGR+3.3%

Colgate-Palmolive Company generated $5.4B in revenue in Q3 2026. This represents an increase of 4.6% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

EBITDA
$1.2B
YoY+2.5%
QoQ+6.5%
5Y CAGR+2.4%

Colgate-Palmolive Company's EBITDA was $1.2B in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 2.5% from the same quarter a year earlier. Against the prior quarter it is up 6.5%.

Net Income
$751.0M
YoY+2.2%
QoQ+8.4%
5Y CAGR+3.4%
10Y CAGR+0.7%

Colgate-Palmolive Company reported $751.0M in net income in Q3 2026. This represents an increase of 2.2% from the same quarter a year earlier. Against the prior quarter it is up 8.4%.

EPS (Diluted)
$0.94
YoY+3.3%
QoQ+9.3%
5Y CAGR+4.6%
10Y CAGR+1.9%

Colgate-Palmolive Company earned $0.94 per diluted share (EPS) in Q3 2026. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is up 9.3%.

Cash & Balance Sheet

Free Cash Flow
$1.0B
YoY-6.2%
QoQ+19.6%
5Y CAGR+3.9%
10Y CAGR+2.0%

Colgate-Palmolive Company generated $1.0B in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 6.2% from the same quarter a year earlier. Against the prior quarter it is up 19.6%.

Cash & Debt
$1.5B
YoY+19.4%
QoQ+11.5%
5Y CAGR+9.8%
10Y CAGR+1.6%

Colgate-Palmolive Company held $1.5B in cash against $7.2B in long-term debt as of Q3 2026.

Dividends Per Share
$0.53
YoY+1.9%
QoQ0.0%
5Y CAGR+3.3%

Colgate-Palmolive Company paid $0.53 per share in dividends in Q3 2026. This represents an increase of 1.9% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
795M
YoY-1.4%
QoQ-0.3%
5Y CAGR-1.2%
10Y CAGR-1.1%

Colgate-Palmolive Company had 795M shares outstanding in Q3 2026. This represents a decrease of 1.4% from the same quarter a year earlier. Against the prior quarter it is down 0.3%.

Margins & Returns

Gross Margin
60.2%
YoY+0.8pp
QoQ-1.3pp
5Y change+0.8pp
10Y change+0.1pp

Colgate-Palmolive Company's gross margin was 60.2% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.

Operating Margin
20.3%
YoY-0.4pp
QoQ+1.3pp
5Y change-1.6pp

Colgate-Palmolive Company's operating margin was 20.3% in Q3 2026, reflecting core business profitability. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Net Margin
14.0%
YoY-0.3pp
QoQ+1.1pp
5Y change-0.4pp
10Y change-4.2pp

Colgate-Palmolive Company's net profit margin was 14.0% in Q3 2026, showing the share of revenue converted to profit. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Return on Equity
260.8%
YoY+174.9pp
QoQ-32.9pp

Colgate-Palmolive Company's quarterly ROE was 260.8% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 174.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 32.9 percentage points.

Capital Allocation

Share Buybacks
$330.0M
YoY+14.6%
QoQ+13.4%
5Y CAGR+5.6%
10Y CAGR-2.6%

Colgate-Palmolive Company spent $330.0M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 14.6% from the same quarter a year earlier. Against the prior quarter it is up 13.4%.

Capital Expenditures
$134.0M
YoY-13.5%
QoQ+4.7%
5Y CAGR-0.4%
10Y CAGR-0.7%

Colgate-Palmolive Company invested $134.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 13.5% from the same quarter a year earlier. Against the prior quarter it is up 4.7%.

R&D Spending

Not reported for Q3 2026.

CL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CL quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$5.4B+4.6%$5.4B+4.9%$5.3B+8.4%$5.2B+5.8%$5.1B+1.9%$5.1B+1.0%$4.9B-3.0%$4.9B-0.1%
Cost of Revenue$2.1B+2.6%$2.1B+1.2%$2.1B+9.0%$2.1B+6.2%$2.1B+6.3%$2.0B+2.5%$1.9B-5.0%$2.0B-1.8%
Gross Profit$3.2B+6.0%$3.3B+7.4%$3.2B+8.0%$3.1B+5.5%$3.0B-0.8%$3.1B+0.1%$3.0B-1.7%$3.0B+1.1%
SG&A Expenses$2.1B+7.1%$2.1B+8.5%$2.1B+9.4%$2.1B+9.3%$2.0B-0.4%$2.0B+1.2%$1.9B-0.9%$1.9B+5.1%
Operating Income$1.1B+2.7%$1.0B-5.9%$964.0M-10.4%$91.0M-91.4%$1.1B-0.6%$1.1B-1.1%$1.1B+2.8%$1.1B-0.7%
EBITDA$1.2B+2.5%$1.2B-4.9%$1.1B-8.5%$264.0M-78.2%$1.2B+0.2%$1.2B-1.4%$1.2B+2.3%$1.2B-0.8%
Interest Expense$62.0M-7.5%$62.0M-12.7%$62.0M-6.1%$63.0M-6.0%$67.0M-9.5%$71.0M-9.0%$66.0M-9.6%$67.0M
Income Tax$240.0M+6.2%$231.0M-1.3%$211.0M-7.0%$111.0M-48.6%$226.0M+7.6%$234.0M-3.7%$227.0M-4.6%$216.0M-5.3%
Net Income$751.0M+2.2%$693.0M-6.7%$646.0M-6.4%-$36.0M-104.9%$735.0M-0.3%$743.0M+1.6%$690.0M+1.0%$738.0M+2.8%
EPS (Basic)$0.94+3.3%$0.87-5.4%$0.81-4.7%-$0.04-104.4%$0.91+1.1%$0.92+3.4%$0.85+2.4%$0.91+4.6%
EPS (Diluted)$0.94+3.3%$0.86-5.5%$0.80-5.9%-$0.04-104.4%$0.91+1.1%$0.91+2.2%$0.85+2.4%$0.90+3.4%
Diluted Shares (Avg)800M-1.3%802M-1.4%805M-1.2%N/A810M-1.5%813M-1.3%815M-1.3%N/A

Not reported in any period shown, so not listed: R&D Expenses.

CL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CL quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$16.7B-4.4%$16.8B-3.9%$16.6B-0.2%$16.3B+1.8%$17.5B+4.4%$17.5B+6.0%$16.6B+0.5%$16.0B-2.1%
Current Assets$6.4B+5.3%$6.3B+5.2%$6.1B+4.6%$5.7B+7.4%$6.0B+4.0%$6.0B+6.2%$5.8B+3.1%$5.3B+0.7%
Cash & Equivalents$1.5B+19.4%$1.4B+12.8%$1.3B+20.1%$1.3B+17.5%$1.3B+3.6%$1.2B+9.5%$1.1B+3.1%$1.1B+13.5%
Short-Term Investments$0n/m$0n/m$0n/m$107.0M-33.1%$0n/m$0n/m$0n/m$160.0M-10.6%
Inventory$2.2B+3.5%$2.2B+2.9%$2.1B-1.8%$2.0B+2.3%$2.1B+3.3%$2.1B+10.3%$2.1B+11.0%$2.0B+2.7%
Accounts Receivable$1.9B+5.2%$2.0B+10.7%$1.9B+9.5%$1.7B+10.1%$1.8B+5.5%$1.8B-2.8%$1.7B-4.9%$1.5B-4.1%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$3.1B-16.8%$3.1B-16.1%$3.1B-6.8%$3.1B-4.6%$3.7B+9.2%$3.7B+11.3%$3.3B-0.2%$3.3B-4.0%
Total Liabilities$16.1B-1.1%$16.2B-1.2%$16.1B+1.3%$16.0B+3.0%$16.3B+2.1%$16.4B+2.6%$15.9B-0.3%$15.5B+0.4%
Current Liabilities$6.6B+2.2%$6.1B-9.3%$5.9B-13.5%$6.9B+19.0%$6.5B+16.7%$6.8B+26.6%$6.9B+29.1%$5.8B+21.5%
Non-Current Liabilities$9.5B-3.2%$10.1B+4.5%$10.2B+12.6%$9.1B-6.5%$9.8B-5.7%$9.6B-9.4%$9.1B-14.9%$9.7B-8.9%
Long-Term Debt$7.2B-1.7%$7.8B+9.5%$7.9B+20.8%$6.9B-5.7%$7.3B-7.6%$7.1B-12.3%$6.6B-19.4%$7.3B-11.3%
Total Equity$288.0M-66.4%$236.0M-66.4%$145.0M-60.1%$54.0M-74.5%$856.0M+96.8%$702.0M+470.7%$363.0M+57.8%$212.0M-65.2%
Retained Earnings$27.4B+1.3%$27.1B+1.3%$26.8B+1.5%$26.6B+1.7%$27.1B+4.8%$26.7B+4.9%$26.4B+5.0%$26.1B+3.4%

CL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CL quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$1.2B-7.1%$995.0M+12.6%$747.0M+24.5%$1.5B+14.5%$1.3B+8.1%$884.0M-10.7%$600.0M-11.9%$1.3B+11.7%
Depreciation & Amortization$159.0M+0.6%$155.0M+2.6%$156.0M+5.4%$173.0M+16.9%$158.0M+5.3%$151.0M-3.8%$148.0M-1.3%$148.0M-1.3%
Stock-Based CompensationN/AN/A$40.0M+73.9%N/AN/AN/A$23.0M+21.1%N/A
Capital Expenditures$134.0M-13.5%$128.0M+18.5%$138.0M+11.3%$177.0M-3.8%$155.0M+15.7%$108.0M-7.7%$124.0M-1.6%$184.0M-6.6%
Free Cash Flow$1.0B-6.2%$867.0M+11.7%$609.0M+27.9%$1.3B+17.6%$1.1B+7.1%$776.0M-11.1%$476.0M-14.2%$1.1B+15.5%
Investing Cash Flow-$137.0Mn/m-$122.0Mn/m-$122.0Mn/m-$103.0Mn/m-$154.0Mn/m-$401.0Mn/m-$159.0Mn/m-$80.0Mn/m
Financing Cash Flow-$858.0Mn/m-$851.0Mn/m-$563.0Mn/m-$1.4Bn/m-$1.0Bn/m-$409.0Mn/m-$458.0Mn/m-$1.3Bn/m
Dividends Paid$429.0M+2.1%$462.0M-2.5%$417.0M+2.7%$523.0M+1.8%$420.0M+2.9%$474.0M+0.2%$406.0M+3.0%$514.0M+1.6%
Share Buybacks$330.0M+14.6%$291.0M+25.4%$306.0M+7.7%$406.0M-10.8%$288.0M-2.4%$232.0M-51.7%$284.0M-44.2%$455.0M+85.7%

CL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CL quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin60.2%+0.8pp61.5%+1.4pp60.6%-0.2pp60.2%-0.1pp59.4%-1.7pp60.1%-0.6pp60.8%+0.8pp60.3%+0.7pp
Operating Margin20.3%-0.4pp18.9%-2.2pp18.1%-3.8pp1.7%-19.8pp20.6%-0.5pp21.1%-0.5pp21.9%+1.2pp21.5%-0.1pp
Net Margin14.0%-0.3pp12.9%-1.6pp12.1%-1.9pp-0.7%-15.6pp14.3%-0.3pp14.5%+0.1pp14.1%+0.6pp14.9%+0.4pp
Return on Equity260.8%+174.9pp293.6%+187.8pp445.5%+255.4pp-66.7%-414.8pp85.9%-83.6pp105.8%-488.5pp190.1%-106.9pp348.1%+230.2pp
Return on Assets4.5%+0.3pp4.1%-0.1pp3.9%-0.3pp-0.2%-4.8pp4.2%-0.2pp4.3%-0.2pp4.1%0.0pp4.6%+0.2pp
Current Ratio0.960.0x1.03+0.1x1.02+0.2x0.83-0.1x0.93-0.1x0.89-0.2x0.85-0.2x0.92-0.2x
Debt-to-Equity24.94+16.4x33.15+23.0x54.74+36.6x127.24+92.9x8.54-9.6x10.18-56.1x18.10-17.3x34.38+20.9x
Liabilities-to-Equity55.91+36.9x68.75+45.4x111.20+67.4x295.65+222.5x19.01-17.6x23.39-106.7x43.84-25.5x73.12+47.8x
Asset Turnover0.320.0x0.320.0x0.320.0x0.320.0x0.290.0x0.290.0x0.300.0x0.310.0x
FCF Margin19.3%-2.3pp16.2%+1.0pp11.4%+1.8pp24.4%+2.5pp21.6%+1.0pp15.2%-2.1pp9.7%-1.3pp21.9%+3.0pp

Note: The current ratio is below 1.0 (0.83), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Colgate-Palmolive Company CL FY2025 $20.4B $2.1B 10.5% $77.0B 61/100
Kimberly-Clark Corp. KMB FY2025 $16.4B $2.0B 12.3% $64.6B 53/100
Unilever plc UL FY2025 $59.3B $11.1B 18.8% $136.4B 56/100
The Estee Lauder Companies Inc. EL FY2026 $15.0B $182.0M 1.2% $36.9B 38/100
Church & Dwight Co., Inc. CHD FY2025 $6.2B $736.8M 11.9% $25.9B 58/100
Clorox Company CLX FY2026 $6.7B $587.0M 8.7% $12.7B 39/100

Frequently Asked Questions

Colgate-Palmolive Company (CL) reported $20.4B in total revenue for fiscal year 2025. This represents a 1.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Colgate-Palmolive Company (CL) revenue grew by 1.4% year-over-year, from $20.1B to $20.4B in fiscal year 2025.

Yes, Colgate-Palmolive Company (CL) reported a net income of $2.1B over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $2.1B, with a net profit margin of 10.5%.

Colgate-Palmolive Company (CL) reported diluted earnings per share of $2.63 for fiscal year 2025. This represents a -25.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Colgate-Palmolive Company (CL) had EBITDA of $3.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Colgate-Palmolive Company (CL) had $1.3B in cash and equivalents against $6.9B in long-term debt.

Colgate-Palmolive Company (CL) had a gross margin of 60.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Colgate-Palmolive Company (CL) had an operating margin of 16.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Colgate-Palmolive Company (CL) had a net profit margin of 10.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Colgate-Palmolive Company (CL) paid $2.08 per share in dividends during fiscal year 2025.

Colgate-Palmolive Company (CL) has a return on equity of 3948.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Colgate-Palmolive Company (CL) generated $3.6B in free cash flow during fiscal year 2025. This represents a 2.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Colgate-Palmolive Company (CL) generated $4.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Colgate-Palmolive Company (CL) had $16.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Colgate-Palmolive Company (CL) invested $564.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Colgate-Palmolive Company (CL) invested $366.0M in research and development during fiscal year 2025.

Yes, Colgate-Palmolive Company (CL) spent $1.2B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Colgate-Palmolive Company (CL) had 802M shares outstanding as of fiscal year 2025.

Colgate-Palmolive Company (CL) had a current ratio of 0.83 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Colgate-Palmolive Company (CL) had a debt-to-equity ratio of 127.24 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Colgate-Palmolive Company (CL) had a liabilities-to-equity ratio of 295.65 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Colgate-Palmolive Company (CL) had a return on assets of 13.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Colgate-Palmolive Company (CL) trades at 37.5x earnings, its market capitalization divided by $2.1B net income, trailing 12 months to September 30, 2026. The market capitalization is $77.0B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Colgate-Palmolive Company (CL) trades at 3.6x sales, its market capitalization divided by $21.3B revenue, trailing 12 months to September 30, 2026. The market capitalization is $77.0B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Colgate-Palmolive Company (CL) has an Altman Z-Score of 7.01, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Colgate-Palmolive Company (CL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Colgate-Palmolive Company (CL) has an earnings quality ratio of 1.97x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Colgate-Palmolive Company (CL) has an interest coverage ratio of 12.38x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Colgate-Palmolive Company (CL) scores 61 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top